Variables | After PSM | |||
---|---|---|---|---|
Univariate | Multivariate | |||
OR (95%CI) | P value | OR (95%CI) | P value | |
Age (>60 vs. ≤60, years) | 1.265 (0.789-2.030) | 0.330 |  |  |
Gender (male vs. female) | 0.884 (0.551-1.418) | 0.609 | Â | Â |
ASA classification (3/4 vs. 1/2) | 3.203 (1.464-7.005) | 0.004 | 2.843 (1.276-6.334) | 0.011 |
Preoperative anemia (<120 vs. ≥120, g/l) | 1.404 (0.853-2.313) | 0.182 |  |  |
Preoperative CEA (>5 vs. ≤5, ng/ml) | 1.198 (0.743-1.930) | 0.459 |  |  |
Preoperative CA19-9 (>37 vs. ≤37, U/ml) | 0.586 (0.304-1.127) | 0.109 |  |  |
Diabetes | 1.036 (0.534-2.009) | 0.917 | Â | Â |
Hypertension | 1.047 (0.622-1.764) | 0.862 | Â | Â |
Surgery access (open vs. laparoscopic) | 1.164 (0.686-1.973) | 0.574 | Â | Â |
Tumor location (ileocecal/ascending colon vs. hepatic flexure colon) | 1.280 (0.797-2.055) | 0.308 | Â | Â |
Operative time (>205 vs. ≤205, min) | 1.805 (1.108-2.939) | 0.018 | 1.723 (1.047-2.836) | 0.032 |
Estimated blood loss (>55 vs. ≤55, ml) | 1.597 (0.991-2.573) | 0.054 |  |  |
pT stage (T3/4 vs. T1/2) | 0.941 (0.382-2.317) | 0.895 | Â | Â |
pN stage (N+ vs. N0) | 1.122 (0.698-1.805) | 0.634 | Â | Â |
Tumor differentiation (grade 3+4 vs. 1+2) | 0.555 (0.185-1.668) | 0.294 | Â | Â |
Histopathology (mucinous/signet ring cell adenocarcinoma vs. adenocarcinoma) | 1.143 (0.710-1.841) | 0.583 | Â | Â |
ALI (low vs. high) | 2.094 (1.288-3.404) | 0.003 | 1.983 (1.209-3.252) | 0.007 |